UCB - Market Capitalization


UCB reported EUR50.68B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alcon AG USD 33.76B 3.29B Jun/2026
Almirall EUR 2.76B 472.53M Dec/2025
Amarin USD 290M 51M Dec/2025
argenx SE USD 46.53B 13.48B Oct/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
Genmab DKK 17.1B 88.06B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 18.98B 27.8B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Orion EUR 10.15B 316M Jun/2026
Recordati EUR 10.44B 184.5M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
UCB EUR 46.41B 13.94B Dec/2025
Unibail Rodamco EUR 13.3B 1.68B Dec/2025